# Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma

> **NCT02823327** · — · TERMINATED · sponsor: **AIDS Malignancy Consortium** · enrollment: 25 (actual)

## Conditions studied

- AIDS-Related Primary Effusion Lymphoma

## Interventions

- **GENETIC:** Laboratory Biomarker Analysis
- **OTHER:** Medical Chart Review

## Key facts

- **NCT ID:** NCT02823327
- **Lead sponsor:** AIDS Malignancy Consortium
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-10-11
- **Primary completion:** 2023-02-03
- **Final completion:** 2023-02-03
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2025-05-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02823327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02823327, "Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02823327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*